Lori Wirth
MD
Medical Director, Head and Neck Cancers
👥Biography 个人简介
Lori Wirth is a leading expert in thyroid and head/neck cancers at Massachusetts General Hospital with a focus on RET-altered malignancies. She was an investigator on the ARROW trial that evaluated pralsetinib in RET-mutant medullary thyroid cancer and RET fusion-positive NSCLC. Her research has advanced treatment options for thyroid cancers driven by kinase alterations.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Lori Wirth 的研究动态
Follow Lori Wirth's research updates
留下邮箱，当我们发布与 Lori Wirth（Massachusetts General Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment